Hims & Hers Health ( ($HIMS) ) has risen by 21.11%. Read on to learn why. Hims & Hers Health has experienced a notable 21.11% ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

More than a third of Hims & Hers public float — over 65 million shares, or about 33.5% — are being sold short, according to data from Benzinga Pro . This level of short interest is well above average ...

Hims & Hers (NYSE:HIMS) stock slips as U.S. lawmakers seek FDA action against copycat versions of weight loss drugs from Novo ...

Reddit is surging with advertiser demand; not everyone is Substack material; and Trump released his AI Action Plan.

In a market note on Wednesday, Zacks Research gave Hims & Hers Health, Inc. (NYSE:HIMS) a “strong buy” recommendation on ...

Telehealth platform Hims & Hers Health (NYSE:HIMS) shot to the top of stock charts yesterday as shares soared 16% high on no company news. While it is revolutionizing access to healthcare by ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

Tesla shares were down about 6% in pretrading on Thursday after reporting a 12% decline in revenue year-on-year. Alphabet ...

Stock indexes in the U.S. moved upward Wednesday as the gained 1.14%. Meanwhile, the increased 0.78%, and the rose 0.61%.

HIMS stock up 16% on Wednesday, continuing month-long gains. Novo Nordisk ends partnership, cites misleading marketing and safety concerns.